Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis

Breast Cancer Research and Treatment

Volumn 52, Issue 1-3, 1998, Pages 147-158

  Heimann, Ruth ^a,b   Ferguson, Donald ^a   Gray, Stacy ^a   Hellman, Samuel ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Age; Angiogenesis; Breast cancer; Immunohistochemistry; Neovascularization; Prognostic factors

Indexed keywords

AGE; ANGIOGENESIS; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCORING SYSTEM; TREATMENT PLANNING; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0032446170     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006123520603     Document Type: Review

References (62)

1. American Cancer Society: Cancer Facts and Figures, 1995
2. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:71-85, 1992
3. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S: A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7:355-366, 1989
4. Quiet CA, Fergason DJ, Weichselbaum RR, Hellman S: Natural history of node-negative breast cancer: a study of 826 patients with long-term follow up. J Clin Oncol 13:1144-1151, 1995
5. Carter CL, Allen C, Henson DE: Relationship of tumor staging, lymph node staging status, and survival in 24,470 breast cancer cases. Cancer 63:181-187, 1989
6. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S: Natural history of node-positive breast cancer: the curability of small cancers with limited number of positive nodes. J Clin Oncol 14:3105-3111, 1996
7. Handley RS: A surgeon's view of the spread of breast cancer. Cancer 24:1231-1234, 1969
8. Lacour J, Le MG, Hill C, Kramar A, Contesso G, Sarrazin D: Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol 13:309-314, 1987
9. Folkman J, Klagsburn M: Angiogenic factors. Science 235:442-443, 1987
10. Folkman J: Clinical application of research on angiogenesis. N Engl J Med 333:1757-1763, 1995
11. Folkman J: Tumor angiogenesis, In: Mendelsohn J, Howley P, Israel A, et al (eds) The Molecular Basis of Cancer. WB Saunders Co., Philadelphia, 1995, pp 206-224
12. Liotta LA, Kleinerman J, Saidel GM: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36:889-894, 1976
13. Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34:997-1004, 1974
14. Killion JJ, Fidler IJ: The biology of tumor metastasis. Semin Oncol 16:105-115, 1989
15. Kohn EC, Liotta LA: Invasion and metastasis: New approaches to an old problem. Oncology 7:47-62, 1993
16. Stracke ML, Liotta LA: Molecular mechanism of tumor cell metastasis. In: Mendelsohn J, Howley P, Israel A, et al (eds) The Molecular Basis of Cancer. WB Saunders Co., Philadelphia, 1995, pp 233-247
17. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1:149-153, 1995
18. Brem S, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48:347-356, 1972
19. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
20. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454-466, 1994
21. Gasparini G: Clinical significance of the determination of angiogenesis in human breast cancer: update of the biological background and overview of the Vicenza studies. Eur J Cancer 32A:2485-2493, 1996
22. Bevilacqua P, Barbareschi M, Verderio P, Boracchi P, Caffo O, Dalla Palina P, Meli S, Weidner N, Gasparini G: Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node negative breast carcinoma - result of a multiparametric study. Breast Cancer Res Treat 36:205-217, 1995
23. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887, 1992
24. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761, 1992
25. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion. Lancet 340:1120-1124, 1992
26. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55:371-374, 1993
27. Obermair A, Kurtz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsh G, Sevelda P: Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence free survival. Int J Cancer 62:126-131, 1995
28. Ogawa Y, Chung YS, Nakata ST, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sakurai M, Sowa M: Microvessel quantitation in invasive breast cancer by staining for factor-VIII-related antigen. Br J Cancer 71:1297-1301, 1995
29. Miliaras D, Kamas A, Kalekou H: Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathol 26:165-169, 1995
30. Aranda FI, Laforga JB: Microvessel quantitation in breast ductal invasive carcinoma. Path Res Pract 192:124-129, 1996
31. Karaiossifidi H, Kouri E, Arvaniti H, Sfikas S, Vasilaros S: Tumor angiogenesis in node-negative breast cancer: relationship with relapse-free survival. Anticancer Res 16:4001-4002, 1996
32. Weidner N, Folkman J: Tumor vascularity as a prognostic factor in cancer. PPO Updates 11:1-24, 1997
33. Gasparini G, Barbareschi M, Boracchi P, Verderio P, Caffo O, Meli S, Dalla Palma P, Marubini E, Bevilacqua P: Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1:131-141, 1995
34. Gasparini G, Fox SB, Verderio P, Bonoldi E, Bevilacqua P, Boracchi P, Dante S, Marubini E, Harris A: Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. Clin Cancer Res 2:1191-1198, 1996
35. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM: Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A:1141-1145, 1993
36. Axelsson K, Ljung BE, Moore Dn, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH: Tumor angiogenesis as a prognostic assay for invasive ductal breast. J Natl Cancer Inst 87:997-1008, 1995
37. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13:765-782, 1995
38. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evalution. Eur J Cancer 32A:2474-2484, 1996
39. Heffelfinger SC, Yassin R, Miller MA, Lower E: Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin Cancer Res 2:1873-1878, 1996
40. Guidi AJ, Fischer L, Harris JR, Schnitt SJ: Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86:614-619, 1994
41. Engels K, Fox SB, Whitehouse RM, Gatter KC, Harris AL: Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol 181:207-212, 1997
42. Lee AHS, Happerfield LC, Borrow LG, Millis RR: Angiogenesis and inflammation in ductal carcinoma in situ of the breast. J Pathol 181:200-206, 1997
43. Paulsen T, Aas T, Borresen A, Varhaug JE, Lonning PE, Akslen LA: Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. Int J Cancer (Pred Oncol) 74:138-140, 1997
44. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S: Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88:1764-1769, 1996
45. Miller RT: Immunohistochemistry in the community practice of pathology. Lab Med 22:527-532, 1991
46. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169-180, 1995
47. Wang MS, Kumar S, Pye D, Haboubi N, Al-Nakib L: Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 86:386-388, 1994
48. Nikoloff BJ: The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 127:523-529, 1991
49. Ramani P, Bradley NJ, Fletcher CDM: QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathol 17:237-242, 1990
50. Vartanian RK, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvesset density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 144:1188-1194, 1994
51. Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Caffo O, Leonardi E, Mauri F, Bevilacqua P, Dalla Palma P: Microvessel density quantification in breast carcinoma. Assessment by light microscopy vs. a computer-aided image analysis system. Appl Immunohistochem 3:75-84, 1995
52. Chalkley HW: Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 4:47-53, 1943
53. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris A: Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177:275-283, 1995
54. Tabar L, Fagenberg G, Duffy SW, Day NE, Gad A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:37-59, 1992
55. Bonnier P, Romaine S, Charpin C, Lejeune C, Tubiana N, Martin PM, Piana L: Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62:138-144, 1995
56. Chung M, Chang HR, Bland KI, Wanebo HJ: Younger women with breast cancer have a poorer prognosis than older women. Cancer 77:97-103, 1996
57. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier JM: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8:591-598, 1990
58. Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, Harris JR: The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 14:3-10, 1988
59. Heimann R, Ferguson D, Powers C, Hellman S: Angiogenesis and estrogen receptor in young women with breast cancer [abstract]. Int J Radiat Oncol Biol Phys 39(2S):136, 1997
60. Jensen HM, Chen I, DeVault MR, Lewis AE: Anglogenesis induced by "normal" human breast tissue: a probable marker for precancer. Science 218:293-295, 1982
61. Hellman S: Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 12:2229-2234, 1994
62. Heimann R, Ferguson D, Recant WM, Hellman S: Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am 4:224-229, 1997